← Eichor
Study identifier: NCT07718204 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients

Condition: Hematopoietic Cell Transplant  ·  Sponsor: Nationwide Children's Hospital

PhaseNA
Planned participants25
Who can joinAll sexes, 0 Years to 12 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to test the MedMemos Intervention with parents and children who have received a bone marrow transplant. The main study questions are: * Is the MedMemos intervention acceptable to patients and families? * Is the MedMemos intervention feasible for patients, families, and healthcare providers? * Does MedMemos help patients and families take their medications better? Participants will be asked to complete surveys, attend 4 intervention sessions, and use an electronic box or pill bottle to store their medications in.

This description comes directly from the study's public registry record.

Talk to the study team

Ahna LH Pai, PhD  ·  (614) 938-1601  ·  Ahna.Pai@nationwidechildrens.org

Sarah N Drake, MS  ·  (614) 259-7462  ·  sarah.drake2@nationwidechildrens.org

Always discuss trial participation with your own doctor first.

Locations (1)

Nationwide Children's HospitalColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07718204